D G Kieback

Leiden University Medical Center — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index4.2kcitations69works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(16), Ovarian cancer diagnosis and treatment(13), Cancer Research and Treatments(13), Estrogen and related hormone effects(10), Cancer-related Molecular Pathways(5)

Publications69 total

Abstract P4-08-02: A Comparison between AQUA Quantitative Fluorescent Immunohistochemistry and Conventional Immunohistochemistry for Hormone Receptors
Cancer Research·2010
Adenovirus-mediated thymidine kinase gene therapy induces apoptosis in human epithelial ovarian cancer cells and damages PARP-1.
PubMed·2009· 3 cited
Adenovirus-mediated thymidine kinase gene therapy and coxsackie adenovirus receptor expression in ovarian cancer cells.
PubMed·2009· 6 cited
Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma
The Journal of Pathology·2005· 42 cited
850 Assessment of Chemotherapy Response in Patients With Ovarian Cancer by in Vivo Detection of Apoptosis Using TC-99-M Labelled Annexin-V
International Journal of Gynecological Cancer·2004
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
Annals of Oncology·2004· 1.7k citedOpen Access
Aggressive Management of Recurrent Ovarian Cancer – the Challenge of Individualizing Cancer Therapy Illustrated by a Case Report
Oncology Research and Treatment·2004· 2 cited
Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer
British Journal of Cancer·2003· 60 citedOpen Access
Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy
Annals of Oncology·2003· 236 citedOpen Access
Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro
Urologic Oncology Seminars and Original Investigations·2003· 12 cited
Combined Gene- and Chemotherapy For Treatment of Ovarian Cancer: In-Vitro Analysis of Combined Treatment With a Replication-Deficient Adenoviral Vector and Topotecan
International Journal of Gynecological Cancer·2003
Adenoviral Mediated Thymidine Kinase Gene Therapy For Ovarian Cancer Using an Estrogeninducible Promoter: A Step Towards Tumor-Specific Gene Therapy
International Journal of Gynecological Cancer·2003
Adnexal Masses in Pregnancy
Oncology Research and Treatment·2003· 52 cited
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types
Journal of Clinical Oncology·2002· 830 cited
Adenovirus-Mediated Thymidine Kinase Gene Therapy for Recurrent Ovarian Cancer: Expression of Coxsackie-Adenovirus Receptor and Integrins αvβ3 and αvβ5
Journal of the Society for Gynecologic Investigation·2002· 17 cited
Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer
International Journal of Gynecological Cancer·2002· 3 cited
Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer
International Journal of Gynecological Cancer·2002· 16 cited
Krisenintervention nach Jacobson als psychoonkologisches Verfahren im Akutstadium
Geburtshilfe und Frauenheilkunde·2001· 1 cited
Was erwarten gynäko-onkologische Patientinnen von ihrem behandelnden Arzt und welche Erfahrungen machen sie? Eine qualitative Untersuchung mit 50 Patientinnen
Geburtshilfe und Frauenheilkunde·2001· 1 cited
Adenovirus-Mediated Thymidine Kinase Gene Therapy in Combination with Topotecan for Patients with Recurrent Ovarian Cancer: 2.5-Year Follow-Up
Gynecologic Oncology·2001· 58 cited
page 1 of 4Next →

Frequent Co-authors

R. Kreienberg(10), Xiaowen Tong(10), Ingo B. Runnebaum(8), Annette Hasenburg(8), Irina U. Agoulnik(8), Petra Kohlberger(7), Volker Möbus(7), Elmar Stickeler(5), Raymond H. Kaufman(5), Estuardo Aguilar-Córdova(5), Christian T. F. Freund(5), Tally Levy(4), A. L. Kaplan(4), Marzenna Orlowska‐Volk(4), Ibrahim Ramzy(4), Charles F. Contant(4), Dirk G. Engehausen(4), Claire F. Verschraegen(3), Ralph S. Freedman(3), M Steger(3)